Stock data
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON) reported net income of -US$161.00M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$190.77M | -US$161.00M | — |
| 2024 | — | — | -US$114.67M | -US$88.04M | — |
| 2023 | — | — | -US$55.45M | -US$48.61M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$79.06M | — |
| 2026-03-31 | — | -US$60.20M | — |
| 2025-12-31 | — | -US$41.31M | — |
| 2025-09-30 | — | -US$43.81M | — |
| 2025-06-30 | — | -US$41.43M | — |
| 2025-03-31 | — | -US$34.45M | — |
| 2024-12-31 | — | -US$31.80M | — |
| 2024-09-30 | — | -US$20.41M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.